$0.15 (0.68%)
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Markus Lusser |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | ABCZF |
| CUSIP | None |
| CIK | 0001492074 |
| Web | https://www.abcam.com |
| Phone | 44 12 2369 6000 |
| Currency | USD |
| Employees | 1760 |
| Country | GB |
Liquidity
| Debt-to-Equity Ratio | 0.35 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.13 |
| Quick Ratio | 0.82 |
| Cash Ratio | 0.51 |
Sales & Book Value
| Annual Sales | $240.98M |
| Price / Sales | 0.00 |
| Cash Flow | 0.01 |
| Price / Cash Flow | 0.00 |
| Price / Book | 3.88 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 5 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $0 |
| Trailing P/E Ratio | 578.30 |
| PEG Ratio | 5.78 |
| P/E Growth | 5.78 |
| Net Income | $135.7M |
| Net Margin | 1.40% |
| Pretax Margin | 1.49% |
| Return on Equity | 0.76% |
| Return on Assets | 0.45% |
Financials Score
| AltmanZ Score | 8.60 |
| Piotroski Score | 9.00 |
| Working Capital | 66.9M |
| Total Assets | 1.03B |
| Ebit | 81.07M |
| Market Cap | 3.82B |
| Total Liabilities | 307.9M |
About Abcam plc (OTC:ABCZF) Stock
Abcam plc is a prominent life sciences firm specializing in the creation, refinement, and provision of specialized agents and instruments crucial for scientific investigation, diagnostic procedures, and pharmaceutical development. Its diverse product portfolio primarily encompasses primary and secondary antibodies, along with conjugated antibodies and their respective conjugation kits. The company also offers singleplex and multiplex immunoassays, a variety of proteins and peptides (such as cytokines), and genetically modified cell lines and lysates. Additionally, their extensive catalog features other essential items like cellular activity kits, miRNA kits, various biochemical compounds, and tools designed for analyzing cell signaling pathways. Abcam caters to a wide clientele, including ... scientists and researchers at academic institutions and governmental research establishments, as well as professionals within the pharmaceutical, biotechnology, and diagnostics sectors. With a global footprint, the company maintains a presence across the Americas, Europe, the Middle East, Africa, China, Japan, and the broader Asia Pacific region. All its offerings are available for purchase directly via its online platform. Established in 1998, Abcam plc maintains its corporate headquarters in Cambridge, United Kingdom.
Frequently Asked Questions
What is the current Abcam plc (ABCZF) stock price?
Abcam plc(OTC:ABCZF) stock price is $22.25 in the last trading session. During the trading session, ABCZF stock reached the peak price of $22.25 while $22.25 was the lowest point it dropped to. The percentage change in ABCZF stock occurred in the recent session was 0.68% while the dollar amount for the price change in ABCZF stock was $0.15.
ABCZF's industry and sector of operation?
The OTC listed ABCZF is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of ABCZF?
Markus Lusser
| President
Amit Kumar Gupta
| Chief Digital Officer
Knud Müller
| Chief Financial Officer
Marc Leigh Russell Perkins
| General Counsel & Company Secretary
Alejandra Solache
| Senior Vice President of Research & Development
How many employees does ABCZF have?
Number of ABCZF employees currently stands at 1760. ABCZF operates from Discovery Drive, Cambridge, None CB2 0AX, GB.
Link for ABCZF official website?
Official Website of ABCZF is: https://www.abcam.com
How do I contact ABCZF?
ABCZF could be contacted at phone #44 12 2369 6000 and can also be accessed through its website. ABCZF operates from Discovery Drive, Cambridge, None CB2 0AX, GB.
How many shares of ABCZF are traded daily?
The average number of ABCZF shares traded daily for last 3 months was 65.
What is the market cap of ABCZF currently?
The market value of ABCZF currently stands at $5.12B with its latest stock price at $22.25